Louvain-La-Neuve, Belgium, Philadelphia, Pennsylvania USA, 17 July 2018 - IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, and the department of Radiation Oncology at Penn Medicine in partnership with OncoLink, proudly present the Fifth Annual Course on Proton Therapy. This will be held on November 16-18, 2018 at Penn Medicine in Philadelphia, Pennsylvania USA.

This unique educational opportunity presents medical professionals and administrators interested in proton therapy with a three-day proton therapy immersion program at Penn Medicine’s Roberts Proton Therapy Center, the largest and most integrated proton center in the world. The fifth presentation of this course will focus on the latest technology available in the field of proton therapy as well as shared expertise on how to build a strong and successful proton therapy center. The Penn Radiation Oncology team will share key insights from all areas of expertise including administration, clinical, physics, therapy, dosimetry, and more based on the successful operations of the Roberts Proton Therapy Center over the past eight years. Sessions are a mix of clinical and administrative topics and cover all aspects of running a thriving Center, including patient experience and patient engagement.

James Metz, MD, Chair, Penn Radiation Oncology and Executive Director, OncoLink:“We are excited to offer this course for the fifth year. As the interest in proton therapy grows both nationally and internationally, Penn’s Roberts Proton Therapy Center continues to be a leader in providing education and training to help develop the next wave of experts in the field. We have been pioneers, both in regards to the technology and in building staff expertise, and we are pleased to showcase our Center and share our experience with the world.”

R. Scott Warwick, Executive Director, The National Association for Proton Therapy: “The Penn Annual course is one of the most informative courses on proton therapy available for physicians, physicists and administrators. I would highly recommend it for anyone who is considering adding proton therapy to their cancer service line.”

Eva Medel Báez, Assistant Professor Radiation Technologies and Medical Physics at the BUAP University in Mexico: “I would encourage all future proton therapy users to attend this course, whether you are an administrator, medical physicist, radiation oncologist, radiation technologist, proton therapy researcher or dosimetrist. My fellow-attendee and I are now armed with multi-fold supporting arguments regarding financing, benefits, administration, development and collaboration options to promote and work towards the acquisition of a proton therapy installation at our own institution.”

Target audiences for the course are: radiation oncology physicians, physicists, and administrators who are interested in learning about proton therapy. At the end of this educational activity, participants should be able to:

Understand the logistics of establishing a proton therapy center with clinical and research capabilities
Describe the current clinical indications and applications for proton therapy
Comprehend the various technical considerations in proton therapy planning
Explain the regulatory aspects of proton therapy planning and delivery from the standpoints of quality assurance and compliance
Better perform their specific roles within the proton therapy center
Build a dedicated patient community who are natural advocates for proton therapy

Details:

When: Friday, November 16, 2018 - Sunday, November 18, 2018

Where: Penn Medicine, Philadelphia, PA, USA

Rad Oncology Homepage